Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2581450 | 0.90 | GAA (0.33) | — | |
| SCHEMBL2584255 | 0.90 | GAA (0.38) | — | |
| SCHEMBL301481 | 0.87 | HRH3 (0.33) | HRH3HTR2AHTR2CHRH1 | |
| SCHEMBL321029 | 0.84 | HTR2A (0.32) | HTR2AHTR2CHRH1 | |
| SCHEMBL320684 | 0.82 | — | — | |
| SCHEMBL302241 | 0.82 | — | — | |
| SCHEMBL303012 | 0.81 | HTR2A (0.33) | HRH3HTR2AHTR2CHRH1 | |
| SCHEMBL301474 | 0.79 | HTR2A (0.37) | HRH3HTR2AHTR2CHRH1 | |
| SCHEMBL301451 | 0.78 | HRH3 (0.34) | HRH3HTR2AHTR2CHRH1 | |
| SCHEMBL21049518 | 0.78 | HRH3 (0.34) | HRH3HTR2AHTR2CHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2404924-B1 | Aqueous solution of piperazinyl-containing silanol compound and making method | SHINETSU CHEMICAL CO (JP) | 2013-03-20 | — | — | EP | disclosed |
| US-20120006229-A1 | AQUEOUS SOLUTION OF PIPERAZINYL-CONTAINING SILANOL COMPOUND AND MAKING METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-01-12 | — | — | US | disclosed |
| EP-2404924-A1 | Aqueous solution of piperazinyl-containing silanol compound and making method | Shin-Etsu Chemical Co., Ltd. (JP) | 2012-01-11 | — | — | EP | disclosed |
| US-8049027-B2 | Organosilicon compound having amino group and its production method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2011-11-01 | — | — | US | disclosed |
| US-20100099866-A1 | ORGANOSILICON COMPOUND HAVING AMINO GROUP AND ITS PRODUCTION METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099866-A1 | ORGANOSILICON COMPOUND HAVING AMINO GROUP AND ITS PRODUCTION METHOD | HRH3, H1-0, H1-2 | HRH3 1/4885HTR2A 927/4885HTR2C 851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.